Forecast

There is no analyst data available for this company.

News Go to news feed

Vidac Pharma: board member Herzberg sells a total of 19,250 shares in two days

Vidac Pharma board member Dr. Max Herzberg sold 11,250 shares on 17 September 2026 at €0.44 each and had already sold 8,000 shares at €0.44 on 16 September 2026. After the managers’ transactions became public, the share briefly rose by 7.00% to €0.46 but remained stable at €0.39 on the day of the BaFin filing. Market capitalisation is around €22.35m with 51,625,060 freely tradable shares. » More on finanzen.net
Vidac Pharma: board member Herzberg sells additional shares

Board member Dr Max Herzberg reported a managers' transaction on 18 September 2026 in which he sold 3,250 Vidac Pharma shares at EUR 0.44 each. On 17 September 2026 Herzberg had already sold 11,250 shares at EUR 0.44 each. The stock last traded at EUR 0.39; Vidac Pharma has a market capitalization of around EUR 22.35 million and a free float of 51,625,060 shares. » More on finanzen.net
Vidac Pharma: board member Herzberg sells 8,000 shares

Board member Dr. Max Herzberg reduced his stake in Vidac Pharma and on 16 September 2026 sold a total of 8,000 shares at €0.44 each. Earlier, on 10 September 2026, he had already sold 5,061 shares at €0.41 each. The stock last traded on the FSE at €0.39; market capitalization is around €21.94 million. » More on finanzen.net